Med-Chemist : "Quintessential Medicinal Chemistry"
Monday, August 8, 2011
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment